Hemophilia 1996: New approach to an old disease

Pediatric Clinics of North America

Volumn 43, Issue 3, 1996, Pages 709-736

  DiMichele, D ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTHROMBIN COMPLEX; AMINOCAPROIC ACID; ANTIFIBRINOLYTIC AGENT; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 CONCENTRATE; BLOOD CLOTTING FACTOR 8 CRYOPRECIPITATE; BLOOD CLOTTING FACTOR 8 INHIBITOR; BLOOD CLOTTING FACTOR 9; BLOOD CLOTTING FACTOR 9 COMPLEX; BLOOD CLOTTING FACTOR 9 CONCENTRATE; DESMOPRESSIN; PREDNISONE; PROTHROMBIN COMPLEX; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RECOMBINANT BLOOD CLOTTING FACTOR 8; TRANEXAMIC ACID;

ADENOVIRUS; BLEEDING DISORDER; BRAIN HEMORRHAGE; CHILD; CLINICAL TRIAL; DRUG PURITY; EPISTAXIS; FLUSHING; GASTROINTESTINAL HEMORRHAGE; GENE MUTATION; GENE THERAPY; GINGIVA BLEEDING; HEMARTHROSIS; HEMATURIA; HEMOPHILIA A; HEMOPHILIA B; HETEROZYGOTE; HUMAN; HYPONATREMIA; INTRANASAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PLASMAPHERESIS; PRACTICE GUIDELINE; PRENATAL DIAGNOSIS; REVIEW; SEIZURE; SUBSTITUTION THERAPY;

EID: 0029974714     PISSN: 00313955     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0031-3955(05)70429-6     Document Type: Article

References (158)

1. J.E. Addiego C. Kasper C. Abildgaard Frequency of inhibitor development in haemophiliacs treated with low-purity factor VIII Lancet 342 1993 462 464
2. J.E. Addiego C. Kasper C. Abildgaard Increased frequency of inhibitors in African-American hemophilia A patients Blood 84 Suppl 1 1994 239A
3. T. Addis The pathogenesis of hereditary haemophilia J Path Bact 15 1911 427
4. A. Ahlberg Haemophilia in Sweden. VII. Incidence, treatment, and prophylaxis of arthropathy and other musculoskeletal manifestations of haemophilia A and B Acta Orthop Scand 77 suppl 1965 7 80
5. L.M. Aledort P.H. Levine M. Hilgartner A study of liver biopsies and disease among hemophiliacs Blood 66 1985 367 372
6. L.M. Aledort H. Pettersson R.H. Haschmeyer A longitudinal study of orthopedic outcomes for severe factor VIII deficient hemophlias J Intern Med 236 1994 391 399
7. H.J. Alter To C or not to C: These are the questions Blood 85 1995 1681 1695
8. R. Biggs A.S. Douglas R.G. Macfarlane Christmas disease: A condition previously mistaken for haemophilia Br Med J 2 1952 1378 1382
9. V.S. Blanchette E. Vorstmann A. Shore Hepatitis C infection in children with hemophilia A and Blood 78 1991 285 289
10. R.D. Bona R.A. Weinstein S.J. Weisman The use of continuous infusion of factor concentrates in the treatment of hemophilia Am J Hematol 32 1989 8 13
11. F.A. Bontempo J.H. Lewis T.J. Gorenc Liver transplantation in hemophilia A Blood 69 1987 1721 1724
12. C.D.K. Bottema D.D. Koeberl S.S. Sommer Direct carrier testing in 14 families with haemophilia B Lancet 2 1989 526 529
13. H.H. Brackmann Induced immunotolerance in factor VIII inhibitor patients Prog Clin Biol Res 150 1984 181 195
14. G.L. Bray E.D. Gomperts S. Courter A multicenter study of recombinant factor VIII (Recombinate): Safety, efficacy, and inhibitor risk in previously untreated patients with hemophilia A Blood 83 1994 2428 2435
15. D. Bresters E.P. Mauser-Bunschoten H.T. Cuypers Disappearance of hepatitis C virus RNA in plasma during interferon alpha-2B treatment in hemophilia patients Scand J Gastroenterol 27 1992 166 168
16. D.B. Brettler H.J. Alter J.L. Dienstag The prevalence of antibody to HCV in a cohort of hemophilic patients Blood 76 1990 254 256
17. D.B. Brettler A.D. Forsberg P.H. Levine The use of procine factor VIII concentrate (Hyate:C) in the treatment of patients with inhibitor antibodies to factor VIII: A multicenter US experience Arch Intern Med 149 1989 1381 1385
18. E. Brit R.M. Bertina van Tilburg N.H. A sex-linked hereditary disorder that improves after puberty N Engl J Med 306 1982 788 790
19. E. Briét H.M. Reisner H.R. Roberts Inhibitors in Christmas disease Prog Clin Biol Res 150 1984 123 129
20. S. Brillanti J. Garson M. Foli A pilot study of combination therapy with ribavirin plus interferon alpha for interferon alfa-resistent chronic hepatitis C Gastroenterology 107 1994 812 817
21. K.M. Brinkhous M. Roberts A.E. Weiss Prevalence of inhibitors in hemophilia A and B Thromb Diath Haemorrh Suppl 51 1972 315 321
22. W. Bulloch P. Fildes Treasury of Human Inheritance, Parts V and VI, Section XIVa, Haemophilia 1911 Dulau & Co. London
23. M. Colombo P.M. Manucci D.M. Brettler Hepatocellular carcinoma in hemophilia Am J Hematol 37 1991 243 246
24. Y. Dai M. Roman R.K. Naviaux Gene therapy via primary myoblasts: Long-term expression of factor IX protein following transplantation in vivo Proc Natl Acad Sci USA 89 1992 10892 10895
25. M.E. Dalton A.H. DeCherney Prenatal diagnosis N Engl J Med 328 1993 114 120
26. Davis G.L. Balart L.A. E.R. Schiff Treatment of chronic hepatitis C with recombinant interferon alpha: A multicenter, randomized, controlled trial. Hepatitis Interventional Therapy Group N Engl J Med 321 1989 1501 1506
27. debiasi R. A. Rocino E. Miraglia The impact of very high-purity factor VIII concentrate on the immune system of human immunodeficiency virus-infected hemophiliacs: A randomized prospective two-year comparison with an intermediate purity concentrate Blood 78 1991 1919 1922
28. D.M. DiMichele Inhibitors in hemophilia: A primer Biomed Prog 8 1995 46 48
29. DiMichele DM, Bell B, Hoots K: A proposed prospective randomized trial of immune tolerance therapy in a pediatric hemophilia A population with high-responding inhibitors: Second International Symposium on Inhibitors to Coagulation Factors. Chapel Hill, North Carolina. November 3, 1993
30. D.M. DiMichele M. Lasak C.H. Miller A study of in vitro factor VIII recovery during delivery of four ultra-pure factor VIII concentrates by continuous infusion: A single institution's experience Am J Hematol 51 1996 99 103
31. S. Ehrenforth W. Kreutz I. Scharrer Incidence of development of factor VIII and factor IX inhibitors in haemophiliacs Lancet 339 1992 594 598
32. N.P. Ewing N.L. Sanders S.L. Dietrich Induction of immune tolerance to factor VIII in hemophiliacs with inhibitors JAMA 259 1988 65 68
33. M.E. Eyster L.S. Diamondstone J.M. Lien Natural history of hepatitis C virus infection in multitransfused hemophiliacs: Effect of coinfection with human immunodeficiency virus. The Multicenter Hemophilia Cohort Study J Acquir Immune Defic Syndr 6 1993 602 610
34. M.E. Eyster F.M. Gill P.M. Blatt Central nervous system bleeding in hemophiliacs Blood 51 1978 1179 1188
35. D.N. Fass G.J. Knutson J.A. Katzmann Monoclonal antibodies to porcine factor VIII coagulant and their use in the isolation of active coagulant protein Blood 59 1982 594 600
36. D.J. Fishman P.K. Jones J. Menitove Detection of the carrier state for classic hemophilia using an enzyme-linked immunosorbent assay (ELISA) Blood 59 1982 1163 1168
37. C.A. Fulcher T.S. Zimmerman Characterization of the human factor VIII procoagulant protein with a heterologous precipitating antibody Proc Natl Acad Sci USA 79 1982 1648 1652
38. F. Giannelli P.M. Green S.S. Sommers Hemophilia B: Database of point mutations and short additions and deletions - fifth edition Nucleic Acids Res 22 1994 3534 3546
39. F.M. Gill S.S. Shapiro W.K. Poole The natural history of factor VIII inhibitors in patients with hemophilia A Prog Clin Biol Res 150 1984 19 29
40. J. Gitschier S. Kogan C. Diamond Genetic basis of hemophilia A Thromb Haemost 66 1991 37 39
41. J. Gitschier W.I. Wood T.M. Goralka Characterization of the human factor VIII gene Nature 312 1984 326 330
42. G.F. Gjerset M.C. Pike J.W. Mosley Effect a low- and intermediate-purity clotting factor therapy on progression of human immunodeficiency virus infection in congenital clotting disorders Blood 84 1994 1666 1671
43. J.J. Goedert C.M. Kessler L.M. Aledort A prospective study of human immunodeficiency virus type I infection and the development of AIDS in subjects with hemophilia N Engl J Med 321 1989 1141 1148
44. J.C. Goldsmith C.K. Kasper P.M. Blatt Coagulation factor IX: Successful surgical experience with a purified factor IX concentrate Am J Hematol 40 1992 210 217
45. E. Gomperts D. Cox S. Courter Long-term safety surveillance in hemophilia A patients receiving a plasma-derived mab purified VIII concentrate Thromb Haemost 65 1991 1160A
46. J.B. Graham Genotype assignment (carrier detection) in the hemophilias Clin Hematol 8 1978 115 145
47. R.A. Gruppo L.P. Valdez R.D. Stout Induction of immune tolerance in patients with hemophilia A and inhibitors Am J Pediatr Hematol Oncol 14 1992 82 87
48. J.B.S. Haldane The rate of spontaneous mutation of a human gene J Genet 31 1935 317 326
49. W.E. Hathaway M.J. Christian S.L. Clarke Comparison of continuous and intermittent factor VIII concentrate therapy in hemophilia A Am J Hematol 17 1984 85 88
50. U. Hedner Experience with recombinant factor VIIa in haemophiliacs Curr Stud Hematol Blood Transfus 58 1991 63 68
51. Hemophilia Information Exchange: Medical and Scientific Advisory Council (MASAC) Recommendations Concerning Prophylaxis. Med Bulletin #193, Chapter Advisory #197, March 11, 1994
52. J.C. Hobbins P.A. Grannum R. Romero Percutaneous umbilical blood sampling Am J Obstet Gynecol 152 1985 1 6
53. R.C. Hoeben F.J. Fallaux N.H.V. Tilburg Toward gene therapy for hemophilia A: Long-term persistence of factor VIII-secreting fibroblasts after transplantation into immunodeficient mice Hum Genet Ther 4 1993 179 186
54. Hoeben R.C. van der Jagt R.C.M. F. Schoute Expression of functional factor VIII in primary human skin fibroblasts after retrovirus-mediated gene transfer J Biol Chem 265 1990 7318 7323
55. W.H. Howell The condition of the blood in haemophilia Am J Physiol 33 1914 13
56. L.W. Hoyer C.A. Carta M.S. Golbus Prenatal diagnosis of classic hemophilia (hemophilia A) by immunoradiometricassays Blood 65 1985 1312 1317
57. M.E. Hrinda C. Huang G.C. Tarr Preclinical studies of a monoclonal antibodypurified factor IX, Mononine Semin Hematol 28 1991 6 14
58. G.I.C. Ingram The history of haemophilia J Clin Pathol 29 1976 3 13
59. D.I. Israel R.J. Kaufman Retroviral-mediated transfer and amplification of a functional human factor VIII gene Blood 75 1990 1074 1080
60. R.L. Janco J.A. Philips P.J. Orlando Detection of hemophilia A carriers using intra genic factor VIII: cDNA polymorphisms Blood 69 1987 1539 1541
61. P.V. Jenkins P.W. Collins E. Goldman Analysis of intron 22 inversions of the factor VIII gene in severe hemophilia A: Implications for genetic counseling Blood 84 1994 2197 2201
62. J. Katz Factor IX inhibitors in patients with hemophilia B: Survey results from 82 treatment centers in the United States and Canada Blood 84 Suppl 1 1994 63A
63. M.A. Kay C.N. Landen S.R. Rothenberg In vivo hepatic gene therapy: Complete albeit transient correction of factor IX deficiency in hemophilia B dogs Proc Natl Acad Sci USA 91 1994 2353 2357
64. Kazazian H.H. Jr The molecular basis of hemophilia A and the present status of carrier and antenatal diagnosis of the disease Thromb Haemost 70 1993 60 62
65. R.A. Kekurck P. Wolf A concentrate of human antihaemophilic factor—its use in six cases of haemophilia Lancet 1 1957 647
66. C.B. Kerr The fortunes of haemophilia in the nineteenth century Med Hist 7 1963 359
67. H.C. Kim K. Klein S. Hirsch Arthroscopic synovectomy in the treatment of hemophilic synovitis Scand J Haematol 33 suppl 40 1984 271 279
68. H.C. Kim C.W. McMillan G.C. White Purified factor IX using monoclonal immunoaffinity technique: Clinical trials in hemophilia B and comparison with prothrombin complex concentrates Blood 79 1992 568 572
69. H.C. Kim C. Smith L. Matts Continuous infusion of factor IX in a patient undergoing surgical procedure Blood 82 Suppl 1 1993 154A
70. H.S. Kingdom J.H. Brauker R.C. Johnson An immunoisolation device which facilitates cell-based prophylactic therapy for hemophilia Blood 82 Suppl 1 1993 447A
71. K. Kiyosawa Y. Akahane A. Nagata Significance of blood transfusion in non-A non-B chronic liver disease in Japan Vox Sang 43 1982 45 52
72. Koerper MA, Heyman MB, Thaler MM: Percutaneous liver biopsy in children with bleeding disorders and hepatitis C infection: Safety of procedure and biopsy results. Liver Disease in Hemophilia Meeting, Atlanta, Georgia, March, 1995
73. W. Kreutz S. Ehrenforth M. Funk Immune tolerance therapy in paediatric haemophilias with factor VIII inhibitors: 14 years' follow-up Haemophilia 1 1995 24 32
74. D. Lakich H. Kazazian S.E. Antonarakis Inversions disrupting the factor VIII gene are a common cause of severe hemophilia A Nat Genet 5 1993 236 241
75. M.R. Lalloz J.H. McVey J.K. Pattenson Haemophilia A diagnosis by analysis of a hyper variable dinucleotide repeat within the factor VIII gene Lancet 338 1991 207 211
76. S. Lane Successful transfusion of blood Lancet 1 1840 185
77. S.A. Larsson Life expectancy of Swedish haemophiliacs, 1831-1980 Br J Haematol 59 1985 593 602
78. Y. Laurian E. Dussaix A. Parquet Transmission of human parvovirus B19 by plasma-derived factor VIII concentrates Nouv Rev Fr Hematol 36 1994 449 453
79. Legg J.W. A Treatise on Haemophilia Sometimes Called the Hereditary Haemorrhagic Diathesis 1872 HK Lewis London
80. S. Lethagen A.S. Harris I.M. Nilsson Intranasal desmopressin (DDAVP) by spray in mild hemophilia A and von Willebrand's disease Type I Blut 60 1990 187 191
81. J.H. Lewis F.A. Bontempo J.A. Spero Liver transplantation in a hemophiliac N Engl J Med 312 1985 1189 1190
82. D.P. Lillicrap B.N. White J.J.A. Holden Carrier detection in the hemophilias Am J Hematol 26 1987 285 296
83. J.N. Lozier K.M. Brinkhous Gene therapy and the hemophilias JAMA 271 1994 47 51
84. J.M. Lusher Prediction and management of adverse events associated with the use of factor IX complex concentrates Semin Hematol 30 Suppl 1 1993 36 40
85. J.M. Lusher P.M. Salzman the Monoclate Study Group Viral safety and inhibitor development associated with factor VIIIC ultra-purified from plasma in hemophiliacs previously unexposed to factor VIIIC concentrates Semin Hematol 27 Suppl 2 1990 1 7
86. J.M. Lusher S. Arkin C.F. Abildgaard Recombinant FVIII in previously untreated subjects with hemophilia A: A 3.5-years observational study of safety, efficacy, and inhibitor development N Engl J Med 328 1993 453 459
87. J.M. Lusher S.S. Shapiro J.E. Palascak Efficacy of prothrombin complex concentrates in hemophiliacs with antibodies to factor VIII N Engl J Med 303 1980 421 425
88. R.G. Macfarlane Thesis for the degree of MD. University of London, 1938. Cited by Biggs CR. Thirty years of haemophilia treatment in Oxford Br J Haematol 13 1967 429 436
89. M. Makris F.E. Preston D.K. Triger Hepatitis C antibody and chronic liver disease in haemophilia Lancet 335 1990 1117 1119
90. M. Makris F.E. Preston D.R. Triger A randomized controlled trial of recombinant interferon-alpha in chronic heptatis C in hemophiliacs Blood 78 1991 1672 1677
91. M.J. Manco-Johnson R. Nuss S. Geraghty A prophylactic program in the United States:Experience and issues Semin Hematol 31 Suppl 2 1994 10 12
92. M. Manco-Johnson R. Nuss R. Kilcoyne Short-term outcome of isotopic synovectomy Blood 84 Suppl 1 1994 200A
93. Mandel J.-L. H.F. Willard R.L. Nussbaum Report of the committee on the genetic constitution of the X chromosome Cytogen cell Genet 49 1988 107 128
94. P.M. Mannucci J.M. Lusher Desmopressin and thrombosis Lancet 2 1989 657 676
95. P.M. Manucci F.I. Pareti Z.M. Ruggeri 1-Deamino-8-D-arginine vasopressin: A new pharmacological approach to the management of hemophilia and von Willebrand's disease Lancet 1 1977 869 872
96. P.M. Mannucci A. Gringeri de Biasi R. Immune status of asymptomatic HIV-infected hemophiliacs: Randomized, prospective, two-year comparison of treatment with a high-purity or an intermediate-purity factor VIII concentrate Thromb Haemost 67 1992 310 313
97. P. Marcellin N. Boyer E. Giostra Recombinant human L-interferon in patients with chronic non-A non-B hepatitis: A multicenter randomized controlled trial from France Hepatology 13 1991 601 603
98. U. Martinowitz S. Schulman S. Gitel Adjusted dose continuous infusion of factor VIII in patients with haemophilia A Br J Haematol 82 1992 729 734
99. J.S. McDougal L.S. Martin S.P. Cort Thermal inactivation of the acquired immunodeficiency syndrome virus, human T-lymphotropic virus III/lymphadenopathy-associated virus, with special reference to antihaemophilic factor J Clin Invest 76 1985 875 877
100. B.C. McLeod R.J. Sassetti E.R. Cole A high-potency single-donor cryoprecipiate of known factor VIII content dispensed in vials Ann Intern Med 2 1988 782 785
101. R.S. Mibashan C.H. Rodeck J.K. Thumpston Plasma assay of fetal factors VIII and IX for prenatal diagnosis of haemophilia Lancet 1 1979 1309 1811
102. J.A. Naylor A. Brinke S. Hassock Characteristic mRNA abnormality found in half the patients with severe haemophilia A is due to large DNA inversions Hum Mol Genet 2 1993 1773 1778
103. J.A. Naylor P.M. Green C.R. Rizza Analysis of factor VIII mRNA reveals defects in everyone of haemophilia A patients Hum Mol Genet 2 1993 11 17
104. I.M. Nilsson E. Berntorp T. Lófquist Twenty-five years experience of prophylactic treatment in severe haemophlia A and B J Intern Med 232 1992 25 32
105. I.M. Nilsson E. Berntorp O. Zettervall Induction of immune tolerance in patients with hemophilia and antibodies to factor VIII by combined treatment with intravenous IgG, cyclophsophamide and factor VIII N Engl J Med 318 1988 947 950
106. H.L. Nossel R.K. Archer R.G. Macfarlane Equine haemophilia: Report of a case and its response to multiple infusions of heterospecific AHG Br J Haematol 8 1962 335
107. J.C. Otto An account of an hemorrhagic disposition existing in certain families Medical Repository 6 1803 1 9
108. M. Pecorara L. Casarino P.G. Mori Hemophilia A: Carrier detection and prenatal diagnosis by DNA analysis Blood 70 1987 531 535
109. K. Peerlinck M. Willems L. Sheng Rapid clearance of hepatitis C virus RNA in peripheral blood mononuclear cells of patients with clotting disorders and chronic hepatitis C treated with alpha-2B interferon is not a predictor for sustained response to treatment Br J Haematol 86 1994 816 819
110. H. Pettersson M. Gilbert Diagnostic imaging in hemophilia: Musculoskeletal and other hemorrhagic complications 1985 Springer-Verlag Berlin 56 65
111. H. Pettersson A. Ahlbert I.M. Nillsson A radiologic classification of hemophlia arthropathy Clin Orthop 149 1980 153 159
112. J.D. Pool A.E. Shannon Production of high-potency concentrates of antihemophilic globulin in a closed bag system N Engl J Med 273 1965 1443
113. A.M. Prince B. Horowitz B. Brotman Sterilization of hepatitis and HTLV-III viruses by exposure to tri (n-butyl) phosphate and sodium chelate Lancet 1 1986 706 710
114. O.D. Ratnoff P.K. Jones Diagnosis of the carrier state in hemophilia (letter) Am J Hematol 28 1988 132
115. 32P chromic phosphate for the treatment of hemophilic arthropathy J Bone Joint Surg 76-A 1994 482 488
116. E.H. Rose L.M. Aledort Nasal spray desmopressin (DDAVP) for mild hemophilia A and von Willebrand disease Ann Intern Med 114 1991 563 568
117. F. Rosner Hemophilia in the Talmud and Rabbinic writings Ann Intern Med 70 1969 833 837
118. G.M. Rumi M. Colombo A. Gringeri High prevalence of antibody to hepatitis C virus in multi-transfused hemophiliacs with normal transaminase levels Ann Intern Med 112 1990 379 380
119. H. Sandberg P. Lind J. Spira Characteristics of a new recominant factor VIII derivative Thromb Haemost 65 1991 942A
120. K. Schimpf P.M. Manucci W. Kreutz Absence of hepatitis after treatment with a pasteurized factor VIII concentrate in patients with hemophilia and no previous transfusion N Engl J Med 316 1987 918 922
121. M.L. Schmidt S. Gamerman H.E. Smith Recombinant activated factor VII (rFVIIa) therapy for intracranial hemorrhage in hemophilia A patients with inhibitors AM J Hematol 47 1994 36 40
122. W. Schramm Experience with prophylaxis in Germany Semin Hematol 30 Suppl 2 1993 12 15
123. S. Schulman B. Weichel Hepatitis, epidemiology, and liver function in hemophiliacs in Sweden Acta Med Scand 215 1984 249 256
124. S. Schulman A.C. Lindgren P. Petrini Transmission of hepatitis C with pasteurized factor Lancet 340 1992 305 306
125. S. Schulman D. Varon N. Keller Monoclonal purified FVIII for continuous infusion: Stability, microbiological safety, and clinical experience Thromb Haemost 72 1994 403 407
126. I. Schwarzinger I. Pabinger C. Korninger Incidence of inhibitors in patients with severe and moderate hemophilia A treated with factor VIII concentrates Am J Hematol 24 1987 241 245
127. L.B. Seeff Z. Buskell-Bales E.C. Wright Long-term mortality after transfusion-associated non-A non-B hepatitis. The National Heart, Lung, and Blood Institute Study Group N Engl J Med 327 1992 1906 1911
128. U. Seligsohn Hemophilia and other clotting disorders Israel J Med Sci 9 1973 1338 1340
129. S.V. Seremetis L.M. Aledort G.E. Bergman Three-year randomized study of high-purity or intermediate-purity factor VIII concentrates in symptom-free HIV-seropositive haemophiliacs: Effects on immune status Lancet 342 1993 700 703
130. A. Shapiro G.E. Bergman Monoclonal antibody purified factor IX: Viral safety in PUPS Blood 82 Suppl 1 1993 64A
131. R.I. Shopnick E. Bolivar D.B. Brettler The incidence of HCV seropositivity in HIV negative children with severe hemophilia A Blood 84 Suppl 1 1994 65A
132. S. Sindet-Pedersen G. Ramstrom S. Bernvil Hemostatic effect of tranexamic acid mouthwash in anticoagulant-treated patients undergoing oral surgery N Engl J Med 320 1989 840 843
133. G.W. Slocombe A.C. Newland M.P. Colvin The role of intensive plasma exchange in the prevention and management of haemorrhage in patients with inhibitors to factor VIII Br J Haematol 47 1981 577 587
134. T.J. Smith J.C. Gill D.R. Ambruso Hyponatremic seizures in young children given DDAVP Am J Hematol 31 1989 199 202
135. S.A. Sommer Assessing the underlying pattern of human germline mutations: Lessons from the factor IX gene FASEB 6 1992 52 59
136. A.C. Stevenson C.B. Kerr On the distribution of frequencies of mutation to genes determining harmful traits in man Mutant Res 4 1967 339 352
137. H.S. Strauss Acquired circulating anticoagulants in hemophilia A N Engl J Med 281 1969 866 873
138. K. Suehiro M. Tanimoto M. Hamaguchi Carrier detection in Japanese hemophilia A by use of three intragenic and two extragenic factor VIII DNA probes: a study of 24 kindreds J Lab Clin Med 112 1988 314 318
139. P. Telfer H. Devereux B. Colvin Alpha interferon for hepatitis C virus infection in haemophilic patients Hemophilia 1 1995 54 58
140. A.R. Thompson Factor IX concentrates for clinical use Thromb Haemost 19 1993 25 36
141. J.J. Toole J.L. Knopf J.M. Wozney Molecular cloning of a cDNA encoding human antihemophilic factor Nature 312 1984 342 347
142. C.L. Troisi F.B. Hollinger W.K. Hoots A multicenter study of viral hepatitis in a United States hemophilic population Blood 81 1993 412 418
143. E.G.D. Tuddenham D.N. Cooper J. Gitscher Haemophilia A: database of nucleotide subsititutions, deletions, insertions, and rearrangements of the factor VIII gene Nucleic Acids Res 19 1991 4821 4833
144. Van Ness M.M. A.M. Diehl Is liver biopsy useful in the evaluation of patients with chronically elevated liver enzymes? Ann Intern Med 111 1989 473 478
145. van den Berg H.M. H.K. Nieuwenhius E.P. Mauser-Bunschoten Hemophilia prophylaxis in the Netherlands Semin Hematol 31 Suppl 2 1994 13 15
146. van Leeuwen E.F. E.P. Mauser-Bunschoten van Dijke P.J. Disappearance of factor VIII:C antibodies in patients with haemophilia A upon frequent administration of factor VIII in intermediate or low dose Br J Haematol 64 1986 291 297
147. M. Wadhwa P. Dilder J. Tubbs Identification of transforming growth factor-B as a contaminant in factor VIII concentrates: A possible link with immunosuppressive effects in hemophiliacs Blood 84 1994 2021 2030
148. N.S. Wang M. Zhang A.R. Thompson A new mutation in the calcium binding domain of factor IX resulting in severe hemophilia B Thromb Haemostas 63 1990 24 26
149. O. Weiland R. Schwarcz R. Wejstal Interferon alpha-2b treatment of chronic post-transfusion non-A non-B hepatitis. Interim results of a randomized controlled open study Scand J Infect Dis 21 1989 127 132
150. R.E. Weinstein R.D. Bona F.R. Rickles Continuous infusion of monoclonal antibody-purified factor Am J Hematol 36 1991 211 212
151. J.D. Wiedel Arthroscopic synovectomy for chronic hemophilic synovitis of the knee Arthoscopy 1 1985 205 209
152. S. Windsor S.A.M. Taylor D. Lillicrap Direct detection of a common inversion mutation in the genetic diagnosis of severe hemophilia A Blood 84 1994 2202 2205
153. W.I. Wood D.J. Capon C.C. Simonsen Expression of active human factor VIII from recombinant DNA clones Nature 312 1984 330 337
154. S.N. Yao K. Kurachi Expression of human factor IX in mice after injection of genetically modified myoblasts Proc Natl Acad Sci USA 89 1992 3357 3361
155. A. Yoshioka O. Nakagawa Y. Uehara In vitro characterization of various heattreated prothrombin complex concentrates (PCC) Thromb Res 46 1987 827 836
156. S. Yoshitake B.G. Schach D.C. Foster Nucleotide sequence of the gene for factor IX (anti-hemophilic factor B) Biochemistry 24 1985 3736 3750
157. K. Zatloukal M. Cotten M. Berger In vivo production of human factor VIII in mice after intrasplenic implantation of primary fibroblasts transfected by receptor-mediated adenovirus-augmented gene delivery Proc Natl Acad Sci USA 91 1994 5148 5152
158. T.S. Zimmerman O.D. Ratnoff A.E. Powell Immunologic differentiation of classic hemophilia (factor VIII deficiency) and von Willebrand's disease J Clin Invest 50 1971 255 258